33 related articles for article (PubMed ID: 29902454)
1. Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model.
Toonen LJA; Overzier M; Evers MM; Leon LG; van der Zeeuw SAJ; Mei H; Kielbasa SM; Goeman JJ; Hettne KM; Magnusson OT; Poirel M; Seyer A; 't Hoen PAC; van Roon-Mom WMC
Mol Neurodegener; 2018 Jun; 13(1):31. PubMed ID: 29929540
[TBL] [Abstract][Full Text] [Related]
2. Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
McLoughlin HS; Moore LR; Chopra R; Komlo R; McKenzie M; Blumenstein KG; Zhao H; Kordasiewicz HB; Shakkottai VG; Paulson HL
Ann Neurol; 2018 Jul; 84(1):64-77. PubMed ID: 29908063
[TBL] [Abstract][Full Text] [Related]
3. MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway.
Long ZW; Wu JH; Cai-Hong ; Wang YN; Zhou Y
Mol Cells; 2018 Jun; 41(6):532-544. PubMed ID: 29902839
[TBL] [Abstract][Full Text] [Related]
4. Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy.
Matos CA; de Almeida LP; Nóbrega C
J Neurochem; 2019 Jan; 148(1):8-28. PubMed ID: 29959858
[TBL] [Abstract][Full Text] [Related]
5. Profiles of brain metastases: Prioritization of therapeutic targets.
Ferguson SD; Zheng S; Xiu J; Zhou S; Khasraw M; Brastianos PK; Kesari S; Hu J; Rudnick J; Salacz ME; Piccioni D; Huang S; Davies MA; Glitza IC; Heymach JV; Zhang J; Ibrahim NK; DeGroot JF; McCarty J; O'Brien BJ; Sawaya R; Verhaak RGW; Reddy SK; Priebe W; Gatalica Z; Spetzler D; Heimberger AB
Int J Cancer; 2018 Dec; 143(11):3019-3026. PubMed ID: 29923182
[TBL] [Abstract][Full Text] [Related]
6. ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4.
Zou H; Chen H; Zhou Z; Wan Y; Liu Z
Cancer Lett; 2019 Dec; 467():19-28. PubMed ID: 31563563
[TBL] [Abstract][Full Text] [Related]
7. The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases.
Potapenko A; Davidson JM; Lee A; Laird AS
Biochem J; 2024 Mar; 481(6):461-480. PubMed ID: 38497605
[TBL] [Abstract][Full Text] [Related]
8. Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity.
Yuan T; Zeng C; Liu J; Zhao C; Ge F; Li Y; Qian M; Du J; Wang W; Li Y; Liu Y; Dai X; Zhou J; Chen X; Ma S; Zhu H; He Q; Yang B
Signal Transduct Target Ther; 2024 Jan; 9(1):11. PubMed ID: 38177135
[TBL] [Abstract][Full Text] [Related]
9. CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion.
Wang S; Iyer R; Han X; Wei J; Li N; Cheng Y; Zhou Y; Gao Q; Zhang L; Yan M; Sun Z; Fang D
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 38038129
[TBL] [Abstract][Full Text] [Related]
10. ATXN3 deubiquitinates YAP1 to promote tumor growth.
Wang S; Liu K; Han X; Cheng Y; Zhao E; Brat DJ; Sun Z; Fang D
Am J Cancer Res; 2023; 13(9):4222-4234. PubMed ID: 37818078
[TBL] [Abstract][Full Text] [Related]
11. The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
Christine A; Park MK; Song SJ; Song MS
Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557
[TBL] [Abstract][Full Text] [Related]
12. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
Zhou L; Chen G; Liu T; Liu X; Yang C; Jiang J
Front Genet; 2022; 13():965805. PubMed ID: 36159990
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria, mitophagy, and the role of deubiquitinases as novel therapeutic targets in liver pathology.
Aryapour E; Kietzmann T
J Cell Biochem; 2022 Oct; 123(10):1634-1646. PubMed ID: 35924961
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells.
Gong B; Zhang J; Hua Z; Liu Z; Thiele CJ; Li Z
Front Oncol; 2021; 11():686898. PubMed ID: 34322387
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention.
Fhu CW; Ali A
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805973
[TBL] [Abstract][Full Text] [Related]
16. Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets.
Zeng C; Zhao C; Ge F; Li Y; Cao J; Ying M; Lu J; He Q; Yang B; Dai X; Zhu H
Front Pharmacol; 2020; 11():1311. PubMed ID: 32982735
[TBL] [Abstract][Full Text] [Related]
17. Measuring Cancer Hallmark Mediation of the TET1 Glioma Survival Effect with Linked Neural-Network Based Mediation Experiments.
Luechtefeld T; Lin N; Paller C; Kuhns K; Laterra JJ; Bressler JP
Sci Rep; 2020 Jun; 10(1):8886. PubMed ID: 32483272
[TBL] [Abstract][Full Text] [Related]
18. Ataxin-3 promotes testicular cancer cell proliferation by inhibiting anti-oncogene PTEN.
Shi Z; Chen J; Zhang X; Chu J; Han Z; Xu D; Gan S; Pan X; Ye J; Cui X
Biochem Biophys Res Commun; 2018 Sep; 503(1):391-396. PubMed ID: 29902454
[TBL] [Abstract][Full Text] [Related]
19. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
Li Y; Gu J; Lu H
Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
